Open AccessPD59-03 EFFICACY AND SAFETY OF TEVERELIX LA, A GNRH ANTAGONIST, IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA (BPH) (CLINICAL TRIAL EP-24332T-A012)
Author(s) -
Steven A. Kaplan,
Carol M. MacLean,
Finn Ole Larsen
Publication year - 2018
Publication title -
the journal of urology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.402
H-Index - 256
eISSN - 1527-3792
pISSN - 0022-5347
DOI - 10.1016/j.juro.2018.02.2803
Subject(s) - medicine , hyperplasia , urology , clinical endpoint , placebo , prostate , clinical trial , lower urinary tract symptoms , benign prostatic hyperplasia (bph) , hormone antagonist , overactive bladder , gynecology , antagonist , pathology , alternative medicine , receptor , cancer
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom